For elderly patients (≥ 70 years old) with advanced non-small cell lung cancer

  • Who have not received prior chemotherapy for their advanced disease
  • Who are not candidates for surgery or radiation therapy

This study is designed to investigate the safety and efficacy of Nab®-Paclitaxel (ABRAXANE®) in combination with Carboplatin as first line treatment.

Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.

For more information about this study: